SaraZarnegar-LumleyMD

Pediatric Hematology & Oncology • Chicago, IL

Physician

Join to view full profile

Dr. Zarnegar-Lumley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zarnegar-Lumley's full profile

Already have an account?

Office
225 E Chicago Ave
Chicago, IL 60611
Phone+1 312-227-4000

Fax+1 615-936-1767

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2017
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2011 - 2014
Georgetown University School of MedicineClass of 2011

Certifications & Licensure

IL State Medical License 2023 - 2026
TN State Medical License 2017 - 2024
NY State Medical License 2014 - 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients Start of enrollment: 2016 Oct 01
Completed
Not Applicable
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation Start of enrollment: 2023 Aug 14
Recruiting
Phase 2

Publications & Presentations

PubMed

Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents.
Kathryn L McElhinney, Samantha K McLean, Sara Zarnegar-Lumley, Monica M Laronda, Erin E Rowell
Pediatric Blood & Cancer. 2024-10-01
2 citations
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.
Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang
Journal of Clinical Oncology. 2024-03-01
15 citations
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun
Blood Advances. 2023-10-10